Often that means crackers, toast, soup, fruit, or other foods that are easy to eat but protein-poor
Ozempic (semaglutide) is currently approved in the USA, EU, Canada, Japan, and Australia 2,3,4,5,6 for the treatment of type 2 diabetes
Step 5: Monitor your response If you decide to continue using the vial after a storage incident, pay close attention to your body response over the next one to two weeks
GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
When to Consider Testing Testing may be useful: Before starting a GLP-1 medicine After a meaningful treatment change When diabetes goals are not being met When persistent gastrointestinal symptoms develop When food or fluid intake has significantly decreased When kidney or liver risk is already present When a prior result was abnormal When a healthcare provider recommends follow-up Testing frequency should be based on individual risk rather than an automatic monthly or quarterly panel for everyone